Skip to main content

Table 3 COX proportional hazard regression analysis of follow-up information for 63 NSCLC patients

From: Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer

    95.0% CI for Exp (B)
P Exp(B) Lower Upper
Stage 0.006 1.813 1.186 2.772
Smoking 0.843 0.895 0.299 2.680
Gender 0.745 0.820 0.248 2.709
Age 0.517 0.985 0.941 1.031